Latest Strategy News

Mayne Pharma has been awarded $13.27 million in legal costs by the Supreme Court of New South Wales after successfully defending against Cosette Pharmaceuticals’ claims tied to a terminated acquisition deal.

Finico Pty Ltd will not extend its unconditional cash offer for DTI Group shares, set to close on 29 May 2026, signaling a major governance shake-up and potential delisting.

TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.

Imugene Limited’s allogeneic CAR T therapy, azer-cel, delivered an 81% overall response rate in a Phase 1b trial cohort of CAR T-naïve patients with various CD19 B-cell malignancies, with updated data due at ASCO 2026.

Lefroy Exploration secures $3.6 million through a share placement to fast-track scoping studies and drilling at its Mt Martin and Burns gold deposits, while awaiting cash flow from Lucky Strike.

Asara Resources continues to unlock substantial high-grade extensions at its Kada Gold Project in Guinea, with recent drilling confirming broad, consistent gold mineralisation beyond existing resources.

Maronan Metals has completed a major share distribution from Red Metal, expanding its shareholder base, while locking in a $22 million strategic investment to fund an ambitious drilling program and feasibility study.

Many Peaks Minerals has raised A$27.5 million through a placement to fund extensive drilling and a pre-feasibility study at its Ferké Gold Project and other Côte d’Ivoire assets.

Appen Limited's FY25 results reveal solid revenue growth driven by generative AI projects and a standout performance from its China segment. The company sets FY26 revenue guidance of $270-300 million, underpinned by operational efficiencies and expanding AI data services.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

Felix Gold’s 2025 drilling at NW Array within the Treasure Creek Project reveals multiple broad zones of near-surface high-grade gold and exceptional antimony mineralisation, reinforcing its dual-commodity strategy amid advancing US critical minerals supply.

PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.